Capricor doubles on Duchenne Hope - Vantage

Capricor doubles on Duchenne Hope  VantageTo hear Capricor Therapeutics' chief executive Linda Marbán tell it, the company started its phase II trial of its Duchenne muscular dystrophy candidate ...